2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol

C114H150F3N17O7 — CID 162064640

IUPAC2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol
SMILESCCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCN3CCOCC3)ccc2n1.CCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCOC)ccc2n1.CCCN(C)c1ccc2nc(C(C)CC)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COc1ccccc1C1CCN(c2nc(C3(C(F)(F)F)CC3)nc3ccc(N(C)CCO)cc23)CC1
InChIInChI=1S/C31H43N5O2.C28H38N4O2.C28H38N4O.C27H31F3N4O2/c1-5-23(2)30-32-28-11-10-25(34(3)16-17-35-18-20-38-21-19-35)22-27(28)31(33-30)36-14-12-24(13-15-36)26-8-6-7-9-29(26)37-4;1-6-20(2)27-29-25-12-11-22(31(3)17-18-33-4)19-24(25)28(30-27)32-15-13-21(14-16-32)23-9-7-8-10-26(23)34-5;1-6-16-31(4)22-12-13-25-24(19-22)28(30-27(29-25)20(3)7-2)32-17-14-21(15-18-32)23-10-8-9-11-26(23)33-5;1-33(15-16-35)19-7-8-22-21(17-19)24(32-25(31-22)26(11-12-26)27(28,29)30)34-13-9-18(10-14-34)20-5-3-4-6-23(20)36-2/h6-11,22-24H,5,12-21H2,1-4H3;7-12,19-21H,6,13-18H2,1-5H3;8-13,19-21H,6-7,14-18H2,1-5H3;3-8,17-18,35H,9-16H2,1-2H3
InChIKeyZAHHYEJKMCEVBQ-UHFFFAOYSA-N
MW1927.56 g/mol
LogP22.35
Rot. Bonds33

About 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol

2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol (PubChem CID 162064640) has the molecular formula C114H150F3N17O7 and a molecular weight of 1927.56 g/mol. Its IUPAC name is 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol.

Molecular Properties

Compound Name2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol
PubChem CID162064640
Molecular FormulaC114H150F3N17O7
Molecular Weight1927.56 g/mol
Exact Mass1926.19
IUPAC Name2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol
SMILESCCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCN3CCOCC3)ccc2n1.CCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCOC)ccc2n1.CCCN(C)c1ccc2nc(C(C)CC)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COc1ccccc1C1CCN(c2nc(C3(C(F)(F)F)CC3)nc3ccc(N(C)CCO)cc23)CC1
InChIInChI=1S/C31H43N5O2.C28H38N4O2.C28H38N4O.C27H31F3N4O2/c1-5-23(2)30-32-28-11-10-25(34(3)16-17-35-18-20-38-21-19-35)22-27(28)31(33-30)36-14-12-24(13-15-36)26-8-6-7-9-29(26)37-4;1-6-20(2)27-29-25-12-11-22(31(3)17-18-33-4)19-24(25)28(30-27)32-15-13-21(14-16-32)23-9-7-8-10-26(23)34-5;1-6-16-31(4)22-12-13-25-24(19-22)28(30-27(29-25)20(3)7-2)32-17-14-21(15-18-32)23-10-8-9-11-26(23)33-5;1-33(15-16-35)19-7-8-22-21(17-19)24(32-25(31-22)26(11-12-26)27(28,29)30)34-13-9-18(10-14-34)20-5-3-4-6-23(20)36-2/h6-11,22-24H,5,12-21H2,1-4H3;7-12,19-21H,6,13-18H2,1-5H3;8-13,19-21H,6-7,14-18H2,1-5H3;3-8,17-18,35H,9-16H2,1-2H3
InChIKeyZAHHYEJKMCEVBQ-UHFFFAOYSA-N
XLogP22.35
TPSA207.89 Ų
H-Bond Donors1
H-Bond Acceptors24
Rotatable Bonds33
Heavy Atoms141
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001927.56
LogP ≤ 522.35
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1024

Analyze 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-((2-(1-Fluorocyclopropyl)-4-(4-(2-methoxyphenyl)piperidin-1-yl)quinazolin-6-yl)(methyl)amino)ethan-1-ol
CID 118610427
2-cyclopropyl-N-ethyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine
CID 90236942
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N,N-dimethylquinazolin-6-amine
CID 90237040
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine
CID 90237274
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine
CID 90237332
2-[[2-Cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]-methylamino]ethanol
CID 90237403
US10118902, Example 174
CID 118610260
US10118902, Example 18
CID 118610314
US10118902, Example 125
CID 118610338
US10118902, Example 47
CID 118610411
US10118902, Example 59
CID 118610423
US10118902, Example 133
CID 118610426

Frequently Asked Questions

What is the IUPAC name of 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol?
The IUPAC name of 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol (CID 162064640) is 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol.
What is the SMILES notation for 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol?
The canonical SMILES for 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol is CCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCN3CCOCC3)ccc2n1.CCC(C)c1nc(N2CCC(c3ccccc3OC)CC2)c2cc(N(C)CCOC)ccc2n1.CCCN(C)c1ccc2nc(C(C)CC)nc(N3CCC(c4ccccc4OC)CC3)c2c1.COc1ccccc1C1CCN(c2nc(C3(C(F)(F)F)CC3)nc3ccc(N(C)CCO)cc23)CC1.
What is the InChIKey of 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol?
The InChIKey is ZAHHYEJKMCEVBQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H43N5O2.C28H38N4O2.C28H38N4O.C27H31F3N4O2/c1-5-23(2)30-32-28-11-10-25(34(3)16-17-35-18-20-38-21-19-35)22-27(28)31(33-30)36-14-12-24(13-15-36)26-8-6-7-9-29(26)37-4;1-6-20(2)27-29-25-12-11-22(31(3)17-18-33-4)19-24(25)28(30-27)32-15-13-21(14-16-32)23-9-7-8-10-26(23)34-5;1-6-16-31(4)22-12-13-25-24(19-22)28(30-27(29-25)20(3)7-2)32-17-14-21(15-18-32)23-10-8-9-11-26(23)33-5;1-33(15-16-35)19-7-8-22-21(17-19)24(32-25(31-22)26(11-12-26)27(28,29)30)34-13-9-18(10-14-34)20-5-3-4-6-23(20)36-2/h6-11,22-24H,5,12-21H2,1-4H3;7-12,19-21H,6,13-18H2,1-5H3;8-13,19-21H,6-7,14-18H2,1-5H3;3-8,17-18,35H,9-16H2,1-2H3.
What are the key properties of 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol?
2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol has a molecular weight of 1927.56 g/mol, XLogP of 22.35, 33 rotatable bonds, 1 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-butan-2-yl-N-(2-methoxyethyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methylquinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-(2-morpholin-4-ylethyl)quinazolin-6-amine;2-butan-2-yl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-N-methyl-N-propylquinazolin-6-amine;2-[[4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-[1-(trifluoromethyl)cyclopropyl]quinazolin-6-yl]-methylamino]ethanol is sourced from PubChem (CID 162064640), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).